3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with raclopride in 12 studies
Studies (3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide) | Trials (3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide) | Recent Studies (post-2010) (3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide) | Studies (raclopride) | Trials (raclopride) | Recent Studies (post-2010) (raclopride) |
---|---|---|---|---|---|
330 | 40 | 33 | 1,802 | 132 | 419 |
Protein | Taxonomy | 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide (IC50) | raclopride (IC50) |
---|---|---|---|
D(2) dopamine receptor | Homo sapiens (human) | 0.052 | |
D(2) dopamine receptor | Mus musculus (house mouse) | 0.032 | |
D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0279 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (8.33) | 18.7374 |
1990's | 5 (41.67) | 18.2507 |
2000's | 5 (41.67) | 29.6817 |
2010's | 1 (8.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Billings, J; Kung, HF; Kung, MP; Murphy, RA | 1 |
Guo, YZ; Kasliwal, R; Kung, HF; Kung, MP; Mach, RH; Pan, SG | 1 |
Billings, J; Chumpradit, S; Kung, HF; Kung, MP; Mach, R | 1 |
Amici, L; Baldessarini, RJ; Baldwin, RM; Fu, X; Innis, RB; Kula, NS; Tamagnan, GD | 1 |
Gmeiner, P; Gründer, G; Hübner, H; Piel, M; Rösch, F; Stark, D | 1 |
Antonini, A; Kirsch, CM; Leenders, KL; Oertel, WH; Schwarz, J; Tatsch, K | 1 |
Dresel, SH; Hou, C; Huang, XF; Kung, HF; Kung, MP; Meegalla, SK; Mu, M; Patselas, G; Plössl, K; Saffer, JR | 1 |
Seeman, P; Tallerico, T | 1 |
Huang, Y; Laruelle, M | 1 |
Cremer, M; Kosinski, CM; Langen, KJ; Meyer, PT; Salber, D; Schaefer, WM; Schiefer, J | 1 |
Brittain, C; Bullich, S; Catafau, AM; Gunn, RN; Laruelle, M; Llop, J; Nucci, G; Suarez, M | 1 |
Bullich, S; Catafau, AM; Cot, A; Gallego, J; Gunn, RN; Laruelle, M; Pavía, J; Ros, D; Suárez, M | 1 |
1 review(s) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and raclopride
Article | Year |
---|---|
Vulnerability of positron emission tomography radiotracers to endogenous competition. New insights.
Topics: Animals; Benzamides; Brain; Dopamine; Humans; Pyrrolidines; Raclopride; Receptors, Dopamine; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2001 |
1 trial(s) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and raclopride
Article | Year |
---|---|
Comparison of 123I-IBZM SPECT and 11C-raclopride PET findings in patients with parkinsonism.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzamides; Carbon Radioisotopes; Humans; Middle Aged; Parkinson Disease; Pyrrolidines; Raclopride; Receptors, Dopamine D2; Regression Analysis; Salicylamides; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1994 |
10 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and raclopride
Article | Year |
---|---|
Synthesis and characterization of iodobenzamide analogues: potential D-2 dopamine receptor imaging agents.
Topics: Animals; Benzofurans; Binding, Competitive; Chemical Phenomena; Chemistry; Corpus Striatum; Iodine Radioisotopes; Isotope Labeling; Male; Molecular Structure; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Tissue Distribution | 1990 |
Dopamine D-2 receptor imaging radiopharmaceuticals: synthesis, radiolabeling, and in vitro binding of (R)-(+)- and (S)-(-)-3-iodo-2-hydroxy-6-methoxy-N- [(1-ethyl-2-pyrrolidinyl)methyl]benzamide.
Topics: Animals; Benzamides; Chemical Phenomena; Chemistry; Corpus Striatum; In Vitro Techniques; Iodine Radioisotopes; Male; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Stereoisomerism; Structure-Activity Relationship | 1988 |
Fluorinated and iodinated dopamine agents: D2 imaging agents for PET and SPECT.
Topics: Animals; Benzamides; Dopamine Agents; Dopamine D2 Receptor Antagonists; Fluorine Radioisotopes; Iodine Radioisotopes; Macaca fascicularis; Male; Pyrrolidines; Radionuclide Imaging; Rats; Rats, Sprague-Dawley; Tissue Distribution; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1993 |
Synthesis and affinity of a possible byproduct of electrophilic radiolabeling of [123I]IBZM.
Topics: Benzamides; Indicators and Reagents; Iodine Radioisotopes; Isotope Labeling; Molecular Structure; Pyrrolidines; Structure-Activity Relationship | 2003 |
In vitro affinities of various halogenated benzamide derivatives as potential radioligands for non-invasive quantification of D(2)-like dopamine receptors.
Topics: Animals; Benzamides; Cell Line; Iodine Isotopes; Radioligand Assay; Receptors, Dopamine D2; Structure-Activity Relationship | 2007 |
Simultaneous SPECT studies of pre- and postsynaptic dopamine binding sites in baboons.
Topics: Animals; Benzamides; Benzofurans; Brain; Carrier Proteins; Cocaine; Dopamine; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Female; Iodine Radioisotopes; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Organotechnetium Compounds; Papio; Pyrrolidines; Raclopride; Radiopharmaceuticals; Receptors, Dopamine; Salicylamides; Tomography, Emission-Computed, Single-Photon; Tropanes | 1999 |
Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine.
Topics: Animals; Antipsychotic Agents; Benzamides; Brain; Carbon Radioisotopes; Cloning, Molecular; Clozapine; Dibenzothiazepines; Dopamine; Dose-Response Relationship, Drug; Humans; Iodine Radioisotopes; Mice; Pyrrolidines; Quetiapine Fumarate; Raclopride; Radionuclide Imaging; Receptors, Dopamine D2; Salicylamides; Spodoptera; Substance Withdrawal Syndrome; Tritium | 1999 |
Comparison of intravenous and intraperitoneal [123I]IBZM injection for dopamine D2 receptor imaging in mice.
Topics: Animals; Autoradiography; Benzamides; Brain; Brain Chemistry; Dopamine Antagonists; Humans; Injections, Intraperitoneal; Injections, Intravenous; Mice; Mice, Inbred C57BL; Mice, Transgenic; Pyrrolidines; Raclopride; Radiopharmaceuticals; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon | 2008 |
Within-subject comparison of striatal D2 receptor occupancy measurements using [123I]IBZM SPECT and [11C]Raclopride PET.
Topics: Adult; Benzamides; Corpus Striatum; Female; Humans; Male; Positron-Emission Tomography; Pyrrolidines; Raclopride; Radiopharmaceuticals; Receptors, Dopamine D2; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2009 |
Impact of scatter correction on D2 receptor occupancy measurements using 123I-IBZM SPECT: comparison to 11C-Raclopride PET.
Topics: Adult; Algorithms; Antipsychotic Agents; Benzamides; Brain; Brain Mapping; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Models, Neurological; Phantoms, Imaging; Positron-Emission Tomography; Pyrrolidines; Raclopride; Receptors, Dopamine D2; Scattering, Radiation; Signal Processing, Computer-Assisted; Tomography, Emission-Computed, Single-Photon | 2010 |